Exploratory Study of Relationships Between Malodor and Urine Metabolomics
NCT ID: NCT02683876
Last Updated: 2020-10-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2016-02-29
2018-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Morbidity Rate for UTI Through Use of PCR-Based Diagnosis and Management
NCT04108910
Pre-analytical Sample Handling Conditions and Their Effects on the Human Urine Metabolome
NCT03063502
Urinalysis Results in Healthy Individuals
NCT04055675
MicroUDxTM: a Rapid Diagnostic Tool That Will Prevent Death and Disability From Common Infections
NCT04228081
Recurrent Urinary Tract Infections and the Microbiome
NCT04831840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with malodor
individuals with self-reported odor issues suspected to be associated with microbial imbalance on or inside the body and inefficient metabolism as evidenced from other laboratory tests
No interventions assigned to this group
Healthy control
individuals not complaining of uncontrollable or unpredictable malodor episodes
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* unpredictable and uncontrollable episodes of malodor
* willing and able to ship a urine sample (in the kit provided) by an overnight courier to Edmonton, Alberta, Canada
* good general health
Exclusion Criteria
* conditions that, in the opinion of the investigator, would prevent participation
* under the age of 18
* elect not to participate in the study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alberta
OTHER
Mebo Research, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Wishart, PhD
Role: PRINCIPAL_INVESTIGATOR
The Metabolomics Innovation Centre (TMIC)
Irene Gabashvili, PhD
Role: PRINCIPAL_INVESTIGATOR
MeBo Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MeBO Research
Miami, Florida, United States
The Metabolomics Innovation Centre
Edmonton, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Emwas AH, Roy R, McKay RT, Ryan D, Brennan L, Tenori L, Luchinat C, Gao X, Zeri AC, Gowda GA, Raftery D, Steinbeck C, Salek RM, Wishart DS. Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis. J Proteome Res. 2016 Feb 5;15(2):360-73. doi: 10.1021/acs.jproteome.5b00885. Epub 2016 Jan 20.
I.S. Gabashvili. Identifying subtypes of a stigmatized medical condition medRxiv 19005223; doi: https://doi.org/10.1101/19005223
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
The Metabolomics Innovation Centre (TMIC)
MeBO Research
Gabashvili, I.S. NCT02683876: Documentation of Clinical Trial Data and Procedures.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201505010014MEBO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.